Browsing Harvard Medical School by Keyword "O antigen"
Now showing items 1-1 of 1
-
Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to Francisella tularensis
(Proceedings of the National Academy of Sciences, 2019-03-14)Francisella tularensis is the causative agent of tularemia, a category A bioterrorism agent. The lipopolysaccharide (LPS) O antigen (OAg) of F. tularensis has been considered for use in a glycoconjugate vaccine, but conjugate ...